Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Multiparametric MRI and PSA Density on the Initial Indication or the Maintaining in Active Surveillance During Follow-Up in low-Risk Prostate Cancer.
Saout K, Zambon A, Nguyen TA, Lucas C, Payrard-Starck C, Segalen T, Tissot V, Doucet L, Marolleau J, Deruelle C, Joulin V, Fourcade A, Fournier G, Valeri A. Saout K, et al. Among authors: fournier g. Clin Genitourin Cancer. 2022 Jun;20(3):e244-e252. doi: 10.1016/j.clgc.2022.01.015. Epub 2022 Jan 31. Clin Genitourin Cancer. 2022. PMID: 35216924
[Idiopathic acute partial renal infarction].
Joulin V, Sallusto F, Deruelle C, Taccoen X, Valeri A, Fournier G. Joulin V, et al. Among authors: fournier g. Prog Urol. 2005 Feb;15(1):75-7. Prog Urol. 2005. PMID: 15822398 Review. French.
Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival.
Taccoen X, Valeri A, Descotes JL, Morin V, Stindel E, Doucet L, Joulin V, Bocqueraz F, Coulange C, Rambeaud JJ, Fournier G, Mejean A; Oncology Committee of the Association Française d'Urologie. Taccoen X, et al. Among authors: fournier g. Eur Urol. 2007 Apr;51(4):980-7. doi: 10.1016/j.eururo.2006.10.025. Epub 2006 Oct 25. Eur Urol. 2007. PMID: 17092632
Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors.
Cussenot O, Azzouzi AR, Nicolaiew N, Mangin P, Cormier L, Fournier G, Valeri A, Cancel-Tassin G. Cussenot O, et al. Among authors: fournier g. Eur Urol. 2007 Oct;52(4):1082-7. doi: 10.1016/j.eururo.2007.04.008. Epub 2007 Apr 13. Eur Urol. 2007. PMID: 17448593
Association between estrogen and androgen receptor genes and prostate cancer risk.
Nicolaiew N, Cancel-Tassin G, Azzouzi AR, Grand BL, Mangin P, Cormier L, Fournier G, Giordanella JP, Pouchard M, Escary JL, Valeri A, Cussenot O. Nicolaiew N, et al. Among authors: fournier g. Eur J Endocrinol. 2009 Jan;160(1):101-6. doi: 10.1530/EJE-08-0321. Epub 2008 Oct 24. Eur J Endocrinol. 2009. PMID: 18952763
495 results